SIMI GEORGE
Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology SAINT CLOUD, FL NPI 1396980397
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology FL NOVARTIS PHARMACEUTICALS CORPORATION All categories
General Payments — all program years on this page
$400.71
- Category: General Payments
- Program years: PY2022–2024
- Record count: 18
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $148.19 across 7 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $148.19 | 7 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| NOVARTIS PHARMACEUTICALS CORPORATION | $52.14 | 2 |
| Daiichi Sankyo Inc. | $38.91 | 2 |
| Mirati Therapeutics, Inc. | $25.14 | 1 |
| Acerta Pharma LLC | $18.69 | 1 |
| Merck Sharp & Dohme Corporation | $13.31 | 1 |
By program year
Records — PY2024 (7)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1086950491 | Novartis Pharmaceuticals Corporation | $26.72 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1086950509 | Novartis Pharmaceuticals Corporation | $25.42 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1089425237 | Daiichi Sankyo Inc. | $25.10 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1089425259 | Daiichi Sankyo Inc. | $13.81 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104587452 | AstraZeneca Pharmaceuticals LP | $18.69 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1117168154 | Mirati Therapeutics, Inc. | $25.14 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1141579330 | Merck Sharp & Dohme LLC | $13.31 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.